Antipsychotic medication, mortality and neurodegeneration: The need for more selective use and lower doses

References

• Alanen , Y. , de Chavez , M. , Silver , A. and Martindale , B. 2009 . Psychotherapeutic approaches to schizophrenic psychoses , London : Routledge .
   Google Scholar
• Ananth , J. , Parameswaran , S. , Gunatilake , S. , Burgoyne , K. and Sidhom , T. 2004 . Neuroleptic malignant syndrome and atypical antipsychotic drugs . Journal of Clinical Psychiatry , 65 : 464 – 470 .
   PubMed Web of Science ®Google Scholar
• Barbui , C. , Nosè , M. , Mazzi , M.A. , Thornicroft , G. , Schene , A. Becker , T. 2006 . Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries . International Clinical Psychopharmacology , 21 : 355 – 362 .
   PubMed Web of Science ®Google Scholar
• Barnes , T.R. and McPhillips , M.A. 1995 . How to distinguish between the neuroleptic‐induced deficit syndrome, depression and disease‐related negative symptoms in schizophrenia . International Clinical Psychopharmacology , 10 (Suppl. 3) : 115 – 121 .
   PubMedGoogle Scholar
• Bentall , R. 2009 . Doctoring the mind: Why psychiatric treatments fail , London : Penguin .
   Google Scholar
• Bola , J.R. 2006 . Medication‐free research in early episode schizophrenia: Evidence of long‐term harm? . Schizophrenia Bulletin , 32 : 288 – 296 .
   PubMed Web of Science ®Google Scholar
• Bola , J.R. , Lehtinen , K. , Cullberg , J. and Ciompi , L. 2009 . Psychosocial treatment, antipsychotic postponement, and low‐dose medication strategies in first‐episode psychosis: A review of the literature . Psychosis: Psychological, Social and Integrative Approaches , 1 : 4 – 18 .
   Google Scholar
• Bonelli , R.M. , Hofmann , P. , Aschoff , A. , Niederwieser , G. , Heuberger , C. Jirikowski , G. 2005 . The influence of psychotropic drugs on cerebral cell death: Female neurovulnerability to antipsychotics . International Clinical Psychopharmacology , 20 : 145 – 149 .
   PubMed Web of Science ®Google Scholar
• Bralet , M.C. , Yon , V. , Loas , G. and Noisette , C. 2000 . Cause of mortality in schizophrenic patients: Prospective study of years of a cohort of 150 chronic schizophrenic patients . Encephale , 26 : 32 – 41 .
   PubMed Web of Science ®Google Scholar
• Brown , S. , Birtwistle , J. , Roe , L. and Thompson , C. 1999 . The unhealthy lifestyle of people with schizophrenia . Psychological Medicine , 29 : 697 – 701 .
   PubMed Web of Science ®Google Scholar
• Cahn , W. , Hulshoff‐Pol , H.E. , Lems , E.B. , van Haren , N.E. , Schnack , H.G. van der Linden , J.A. 2002 . Brain volume changes in first‐episode schizophrenia: A 1‐year follow‐up study . Archives of General Psychiatry , 59 (11) : 1002 – 1010 .
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention . 2003 . Prevalence of diabetes and impaired fasting glucose in adults – United States, 1999–2000 . Morbidity and Mortaloty Weekly Report , 52 : 833 – 837 .
   PubMedGoogle Scholar
• Citrome , L. 2007 . The effectiveness criterion: Balancing efficacy against the risks of weight gain . Journal of Clinical Psychiatry , 68 (Suppl. 12) : 12 – 17 .
   PubMedGoogle Scholar
• Citrome , L. , Jaffe , A. , Levine , J. , Allingham , B. and Robinson , J. 2004 . Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients . Psychiatric Services , 55 : 1006 – 1013 .
   PubMed Web of Science ®Google Scholar
• Correll , C.U. , Frederickson , A.M. , Kane , J.M. and Manu , P. 2006 . Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second‐generation antipsychotic drugs . Journal of Clinical Psychiatry , 67 : 575 – 583 .
   PubMed Web of Science ®Google Scholar
• Correll , C.U. , Frederickson , A.M. , Kane , J.M. and Manu , P. 2007 . Does antipsychotic polypharmacy increase the risk for metabolic syndrome? . Schizophrenia Research , 89 : 91 – 100 .
   PubMed Web of Science ®Google Scholar
• Correll , C.U. and Schenk , E.M. 2008 . Tardive dyskinesia and new antipsychotics . Current Opinion in Psychiatry , 21 : 151 – 156 .
   PubMed Web of Science ®Google Scholar
• Correll , C.U. , Manu , P. , Olshanskiy , V. , Napolitano , B. , Kane , J.M. and Malhotra , A.K. 2009 . Cardiometabolic risk of second‐generation antipsychotic medications during first‐time use in children and adolescents . Journal of the American Medical Association , 28 : 1765 – 1773 .
   Google Scholar
• Daumit , G.L. , Goff , D.C. , Meyer , J.M. , Davis , V.G. , Nasrallah , H.A. McEvoy , J.P. 2008 . Antipsychotic effects on estimated 10‐year coronary heart disease risk in the CATIE schizophrenia study . Schizophrenia Research , 105 : 175 – 187 .
   PubMed Web of Science ®Google Scholar
• Dazzan , P. , Morgan , K.D. , Orr , K. , Hutchinson , G. , Chitnis , X. Suckling , J. 2005 . Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: The AESOP study . Neuropsychopharmacology , 30 : 765 – 774 .
   PubMed Web of Science ®Google Scholar
• Dean , C.E. 2006 . Antipsychotic‐associated neuronal changes in the brain: Toxic, therapeutic, or irrelevant to the long‐term outcome of schizophrenia? . Progress in Neuropsychopharmacology & Biological Psychiatry , 30 : 174 – 189 .
   PubMed Web of Science ®Google Scholar
• Dean , C.E. and Thuras , P.D. 2009 . Mortality and tardive dyskinesia: Long‐term study using the US National Death Index . British Journal of Psychiatry , 194 : 360 – 364 .
   PubMed Web of Science ®Google Scholar
• de Leon , J. 2008 . Beyond the “hype” on the association between metabolic syndrome and atypical antipsychotics: The confounding effects of cohort, typical antipsychotics, severe mental illness, comedications, and comorbid substance use . Journal of Clinical Psychopharmacology , 28 : 125 – 131 .
   PubMed Web of Science ®Google Scholar
• deHaan , L. , Booij , J. , Lavalaye , J. , van , A.T. and Linszen , D. 2006 . Occup ancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia . Psychopharmacology (Berlin) , 183 : 500 – 505 .
   PubMed Web of Science ®Google Scholar
• Dorph‐Petersen , K.A. , Pierri , J.N. , Perel , J.M. , Sun , Z. , Sampson , A.R. and Lewis , D.A. 2005 . The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys . Neuropsychopharmacology , 30 : 1649 – 1661 .
   PubMed Web of Science ®Google Scholar
• Enger , C. , Weatherby , L. , Reynolds , R.F. , Glasser , D.B. and Walker , A.M. 2004 . Serious cardiovascular events and mortality among patients with schizophrenia . Journal of Nervous and Mental Disease , 192 : 19 – 27 .
   PubMed Web of Science ®Google Scholar
• Ford , E.S. , Giles , W.H. and Dietz , W.H. 2002 . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey . Journal of the American Medical Association , 287 : 356 – 359 .
   PubMed Web of Science ®Google Scholar
• Galili‐Mosberg , R. , Gil‐Ad , I. , Weizman , A. , Melamed , E. and Often , D. 2000 . Haloperidol‐induced neurotoxicity – Possible implications for tardive dyskinesia . Journal of Neural Transmission , 107 : 479 – 490 .
   PubMed Web of Science ®Google Scholar
• Garver , D.L. , Holcomb , J.A. and Christensen , J.D. 2005 . Cerebral cortical gray expansion associated with two second‐generation antipsychotics . Biological Psychiatry , 58 : 62 – 66 .
   PubMed Web of Science ®Google Scholar
• Garver , D.L. , Nair , T.R. , Christensen , J.D. , Holcomb , J.A. and Kingsbury , S.J. 2000 . Brain and ventricle instability during psychotic episodes of the schizophrenias . Schizophrenia Research , 44 : 11 – 23 .
   PubMed Web of Science ®Google Scholar
• Gilbert , P.L. , Harris , M.J. , McAdams , L.A. and Jeste , D.V. 1995 . Neuroleptic withdrawal in schizophrenic patients. A review of the literature . Archives of General Psychiatry , 52 : 173 – 188 .
   PubMed Web of Science ®Google Scholar
• Glassman , A.H. 2005 . Schizophrenia, antipsychotic drugs, and cardiovascular disease . Journal of Clinical Psychiatry , 66 (Suppl. 6) : 5 – 10 .
   PubMedGoogle Scholar
• Glassman , A.H. and Bigger , J.T. Jr. 2001 . Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death . American Journal of Psychiatry , 158 : 1774 – 1782 .
   PubMed Web of Science ®Google Scholar
• Grundy , S.M. , Brewer , H.B. Jr. , Cleeman , J.I. , Smith , S.C. Jr. , Lenfant , C. and National Heart, Lung, and Blood Institute, American Heart Association . 2004 . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition . Circulation , 109 : 433 – 438 .
   PubMed Web of Science ®Google Scholar
• Gur , R.E. , Maany , V. , Mozley , P.D. , Swanson , C. , Bilker , W. and Gur , R.C. 1998 . Subcortical MRI volumes in neuroleptic‐naive and treated patients with schizophrenia . American Journal of Psychiatry , 155 : 1711 – 1717 .
   PubMed Web of Science ®Google Scholar
• Haddad , P.M. and Anderson , I.M. 2002 . Antipsychotic‐related QTc prolongation, torsade de pointes and sudden death . Drugs , 62 : 1649 – 1671 .
   PubMed Web of Science ®Google Scholar
• Hagg , S. , Bate , A. , Stahl , M. and Spigset , O. 2008 . Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions . Drug Safety , 31 : 685 – 694 .
   PubMed Web of Science ®Google Scholar
• Halim , N.D. , Weickert , C.S. , McClintock , B.W. , Weinberger , D.R. and Lipska , B.K. 2004 . Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus . Neuropsychopharmacology , 29 (6) : 1063 – 1069 .
   PubMed Web of Science ®Google Scholar
• Haukka , J. , Tiihonen , J. , Harkanen , T. and Lonnqvist , J. 2008 . Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia . Pharmacoepidemiology and Drug Safety , 17 : 686 – 696 .
   PubMed Web of Science ®Google Scholar
• Henderson , D.C. , Nguyen , D.D. , Copeland , P.M. , Hayden , D.L. , Borba , C.P. Louie , P.M. 2005 . Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: Results of a 10‐year naturalistic study . Journal of Clinical Psychiatry , 66 : 1116 – 1121 .
   PubMed Web of Science ®Google Scholar
• Hennessy , S. , Bilker , W.B. , Knauss , J.S. , Margolis , D.J. , Kimmel , S.E. Reynolds , R.F. 2002 . Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: Cohort study using administrative data . British Medical Journal , 325 : 1070
   PubMed Web of Science ®Google Scholar
• Ho , B.C. , Andreasen , N.C. , Nopoulos , P. , Arndt , S. , Magnotta , V. and Flaum , M. 2003 . Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia . Archives of General Psychiatry , 60 (6) : 585 – 594 .
   PubMed Web of Science ®Google Scholar
• Jeste , D.B. and Wyatt , R.J. 1981 . Changing epidemiology of tardive dyskinesia: An overview . American Journal of Psychiatry , 138 : 297 – 309 .
   PubMed Web of Science ®Google Scholar
• Jones , P.B. , Barnes , T.R. , Davies , L. , Dunn , G. , Lloyd , H. Hayhurst , K.P. 2006 . Randomized controlled trial of the effect on Quality of Life of second‐ vs first‐generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) . Archives of General Psychiatry , 63 : 1079 – 1087 .
   PubMed Web of Science ®Google Scholar
• Joseph , K.S. , Blais , L. , Ernst , P. and Suissa , S. 1996 . Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers . British Medical Journal , 312 : 79 – 82 .
   PubMedGoogle Scholar
• Joukamaa , M. , Heliovaara , M. , Knekt , P. , Aromaa , A. , Raitasalo , R. and Lehtinen , V. 2006 . Schizophrenia, neuroleptic medication and mortality . British Journal of Psychiatry , 188 : 122 – 127 .
   PubMed Web of Science ®Google Scholar
• Kapur , S. , Agid , O. , Mizrahi , R. and Li , M. 2006 . How antipsychotics work – From receptors to reality . NeuroRx , 3 : 10 – 21 .
   PubMedGoogle Scholar
• Keshavan , M.S. , Bagwell , W.W. , Haas , G.L. , Sweeney , J.A. , Schooler , N.R. and Pettegrew , J.W. 1994 . Changes in caudate volume with neuroleptic treatment . Lancet , 344 (8934) : 1434
   PubMed Web of Science ®Google Scholar
• Konopaske , G.T. , Dorph‐Petersen , K.‐A. , Sweet , R.A. , Pierri , J.N. , Zhang , W. Sampson , A.R. 2008 . Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys . Biological Psychiatry , 63 : 759 – 765 .
   PubMed Web of Science ®Google Scholar
• Lacro , J. , Dunn , L. and Dolder , C. 2002 . Prevalence of risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review . Journal of Cognitive Psychotherapy , 17 : 375 – 383 .
   Google Scholar
• Leslie , D.L. , Mohamed , S. and Rosenheck , R.A. 2009 . Off‐label use of antipsychotic medications in the department of Veterans Affairs health care system . Psychiatric Services , 60 : 1175 – 1181 .
   PubMed Web of Science ®Google Scholar
• Lieberman , J. , Chakos , M. , Wu , H. , Alvir , J. , Hoffman , E. Robinson , D. 2001 . Longitudinal study of brain morphology in first episode schizophrenia . Biological Psychiatry , 49 : 487 – 499 .
   PubMed Web of Science ®Google Scholar
• Lieberman , J.A. , Stroup , T.S. , McEvoy , J.P. , Swartz , M.S. , Rosenheck , R.A. Perkins , D.O. 2005a . Effectiveness of antipsychotic drugs in patients with chronic schizophrenia . New England Journal of Medicine , 353 : 1209 – 1223 .
   PubMed Web of Science ®Google Scholar
• Lieberman , J.A. , Tollefson , G.D. , Charles , C. , Zipursky , R. , Sharma , T. Kahn , R.S. 2005b . Antipsychotic drug effects on brain morphology in first‐episode psychosis . Archives of General Psychiatry , 62 : 361 – 370 .
   PubMed Web of Science ®Google Scholar
• Loas , G. , Azi , A. , Noisette , C. and Yon , V. 2008 . [Mortality among chronic schizophrenic patients: A prospective 14‐year follow‐up study of 150 schizophrenic patients.] [In French.] . Encephale , 34 : 54 – 60 .
   PubMed Web of Science ®Google Scholar
• Madsen , A.L. , Karle , A. , Rubin , P. , Cortsen , M. , Andersen , H.S. and Hemmingsen , R. 1999 . Progressive atrophy of the frontal lobes in first‐episode schizophrenia: Interaction with clinical course and neuroleptic treatment . Acta Psychiatrica Scandinavica , 100 : 367 – 374 .
   PubMed Web of Science ®Google Scholar
• Madsen , A.L. , Keidling , N. , Karle , A. , Esbjerg , S. and Hemmingsen , R. 1998 . Neuroleptics in progressive structural brain abnormalities in psychiatric illness . Lancet , 352 (9130) : 784 – 785 .
   PubMed Web of Science ®Google Scholar
• Manderscheid , R.W. 2009 . Premature death among state mental health agency consumers: Assessing progress in addressing a quiet tragedy . International Journal of Public Health , 54 : 1 – 2 .
   Web of Science ®Google Scholar
• McClure , R.K. , Phillips , I. , Jazayerli , R. , Barnett , A. , Coppola , R. and Weinberger , D.R. 2006 . Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment . Psychiatry Research , 148 : 121 – 132 .
   PubMed Web of Science ®Google Scholar
• McEvoy , J.P. , Meyer , J.M. , Goff , D.C. , Nasrallah , H.A. , Davis , S.M. Sullivan , L. 2005 . Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III . Schizophrenia Research , 80 : 19 – 32 .
   PubMed Web of Science ®Google Scholar
• Mehta , D. , Mallya , A. and Volavka , J. 1978 . Mortality of patients with tardive dyskinesia . American Journal of Psychiatry , 135 : 371 – 372 .
   PubMed Web of Science ®Google Scholar
• Meyer , J.M. 2007 . Stategies for the long‐term treatment of schiziophrenia: Real‐world lessons from the CATIE Trial . Journal of Clinical Psychiatry , 68 (Suppl. 1) : 28 – 33 .
   PubMedGoogle Scholar
• Meyer , J.M. , Nasrallah , H.A. , McEvoy , J.P. , Goff , D.C. , Davis , S.M. Chakos , M. 2005 . The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome . Schizophrenia Research , 80 : 9 – 18 .
   PubMed Web of Science ®Google Scholar
• Miller , d.D. , Caroff , S.N. , Davis , S.M. , Rosenheck , R.A. , McEvoy , J.P. Saltz , B.L. 2008 . Extrapyramidal side‐effects of antipsychotics in a randomised trial . British Journl of Psychiatry , 193 : 279 – 288 .
   PubMed Web of Science ®Google Scholar
• Mitchell , A.J. and Malone , D. 2006 . Physical health and schizophrenia . Current Opinion in Psychiatry , 19 : 432 – 437 .
   PubMed Web of Science ®Google Scholar
• Modestin , J. , Vogt‐Wehrli , M. , Stephan , P.L. and Agarwalla , P. 2009 . Relationship between neuroleptic extrapyramidal syndromes and patients’ all‐cause mortality . Pharmacopsychiatry , 42 : 57 – 60 .
   PubMed Web of Science ®Google Scholar
• Molina , V. , Reig , S. , Sanz , J. , Palomo , T. , Benito , C. Sanchez , J. 2005 . Increase in gray matter and decrease in white matter volumes in the cortex during treatment with atypical neuroleptics in schizophrenia . Schizophrenia Research , 80 : 61 – 71 .
   PubMed Web of Science ®Google Scholar
• Montout , C. , Casadebaig , F. , Lagnaoui , R. , Verdoux , H. , Philippe , A. Begaud , B. 2002 . Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients . Schizophrenia Research , 57 : 147 – 156 .
   PubMed Web of Science ®Google Scholar
• Morgan , M.G. , Scully , P.J. , Youssef , H.A. , Kinsella , A. , Owens , J.M. and Waddington , J.L. 2003 . Prospective analysis of premature mortality in schizophrenia in relation to health service engagement: A 7.5‐year study within an epidemiologically complete, homogeneous population in rural Ireland . Psychiatry Research , 117 : 127 – 135 .
   PubMed Web of Science ®Google Scholar
• Nasrallah , H.A. 2008 . Atypical antipsychotic‐induced metabolic side effects: Insights from receptor‐binding profiles . Molecular Psychiatry , 13 : 27 – 35 .
   PubMed Web of Science ®Google Scholar
• National Association of State Mental Health Program Directors Medical Directors Council . 2006 . “ Morbidity and Mortality in People with Serious Mental Illness (Rep. No. 13 Technical Report) ” .
   Google Scholar
• National Institute for Health and Clinical Excellence (NICE) . 2009 . Core interventions in the treatment and management of schizophrenia in primary and secondary care (update) , London : NICE .
   Google Scholar
• Navari , S. and Dazzan , P. 2009 . Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings . Psychological Medicine , 39 : 1763 – 1777 .
   PubMed Web of Science ®Google Scholar
• Noh , J.S. , Kang , H.J. , Kim , E.Y. , Sohn , S. , Chung , Y.K. Kim , S.U. 2000 . Haloperidol‐induced neuronal apoptosis: Role of p38 and c‐Jun‐NH(2)‐terminal protein kinase . Journal of Neurochemistry , 75 : 2327 – 2334 .
   PubMed Web of Science ®Google Scholar
• Osborn , D.P. , Levy , G. , Nazareth , I. , Petersen , I. , Islam , A. and King , M.B. 2007 . Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom’s General Practice Research Database . Archives of General Psychiatry , 64 : 242 – 249 .
   PubMed Web of Science ®Google Scholar
• Osborn , D.P. , Nazareth , I. and King , M.B. 2007 . Physical activity, dietary habits and Coronary Heart Disease risk factor knowledge amongst people with severe mental illness: A cross sectional comparative study in primary care . Social Psychiatry and Psychiatric Epidemiology , 42 : 787 – 793 .
   PubMed Web of Science ®Google Scholar
• Pandurangi , A.K. and Dalkilic , A. 2008 . Polypharmacy with second‐generation antipsychotics: A review of evidence . Journal of Psychiatric Practice , 14 : 345 – 367 .
   PubMed Web of Science ®Google Scholar
• Pantelis , C. , Yücel , M. , Wood , S.J. , Velakoulis , D. , Sun , D. Berger , G. 2005 . Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia . Schizophrenia Bulletin , 31 : 672 – 696 .
   PubMed Web of Science ®Google Scholar
• Ray , W.A. 2005 . Observational studies on drugs and mortality . New England Journal of Medicine , 353 : 2319 – 2321 .
   PubMed Web of Science ®Google Scholar
• Ray , W.A. , Chung , C.P. , Murray , K.T. , Hall , K. and Stein , C.M. 2009 . Atypical antipsychotic drugs and the risk of sudden cardiac death . New England Journal of Medicine , 360 : 225 – 235 .
   PubMed Web of Science ®Google Scholar
• Ray , W.A. , Meredith , S. , Thapa , P.B. , Meador , K.G. , Hall , K. and Murray , K.T. 2001 . Antipsychotics and the risk of sudden cardiac death . Archives of General Psychiatry , 58 : 1161 – 1167 .
   PubMed Web of Science ®Google Scholar
• Reist , C. , Mintz , J. , Albers , L.J. , Jamal , M.M. , Szabo , S. and Ozdemir , V. 2007 . Second‐generation antipsychotic exposure and metabolic‐related disorders in patients with schizophrenia: An observational pharmacoepidemiology study from 1988 to 2002 . Journal of Clinical Psychopharmacology , 27 : 46 – 51 .
   PubMed Web of Science ®Google Scholar
• Rosenheck , R.A. , Leslie , D.L. , Sindelar , J. , Miller , E A. , Lin , H. Stroup , T.S. 2006 . Cost‐effectiveness of second‐generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia . American Journal of Psychiatry , 163 : 2080 – 2089 .
   PubMed Web of Science ®Google Scholar
• Saha , S. , Chant , D. and McGrath , J. 2007 . A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? . Archives of General Psychiatry , 64 : 1123 – 1131 .
   PubMed Web of Science ®Google Scholar
• Scherk , H. and Falkai , P. 2006 . Effects of antipsychotics on brain structure . Current Opinion in Psychiatry , 19 : 145 – 150 .
   PubMed Web of Science ®Google Scholar
• Sengupta , S. , Parrilla‐Escobar , M.A. , Klink , R. , Fathalli , F. , Ying , K. N. Stip , E. 2008 . Are metabolic indices different between drug‐naive first‐episode psychosis patients and healthy controls? . Schizophrenia Research , 102 : 329 – 336 .
   PubMed Web of Science ®Google Scholar
• Shenton , M.E. , Dickey , C.C. , Frumin , M. and McCarley , R.W. 2001 . A review of MRI findings in schizophrenia . Schizophrenia Research , 49 : 1 – 52 .
   PubMed Web of Science ®Google Scholar
• Sicouri , S. and Antzelevitch , C. 2008 . Sudden cardiac death secondary to antidepressant and antipsychotic drugs . Expert Opinion in Drug Safety , 7 : 181 – 194 .
   PubMed Web of Science ®Google Scholar
• Smieskova , R. , Fusar‐Poli , P. , Allen , P. , Bendfeldt , K. , Stieglitz , R.D. Drewe , J. 2009 . The effects of antipsychotics on the brain: What have we learnt from structural imaging of schizophrenia? – A systematic review . Current Pharmaceutical Design , 15 : 2535 – 2549 .
   PubMed Web of Science ®Google Scholar
• Suvisaari , J. , Perala , J. , Saarni , S.I. , Harkanen , T. , Pirkola , S. Joukamaa , M. 2008 . Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey . European Archives of Psychiatry and Clinical Neuroscience , 258 : 129 – 136 .
   PubMed Web of Science ®Google Scholar
• Thompson , P.M. , Bartzokis , G. , Hayashi , K.M. , Klunder , A.D. , Lu , P.H. Edwards , N. 2009 . Time‐lapse mapping of cortical changes in schizophrenia with different treatments . Cerebral Cortex , 19 : 1107 – 1123 .
   PubMed Web of Science ®Google Scholar
• Tiihonen , J. , Walhbeck , K. , Lonnqvist , J. , Klaukka , T. , Ioannidis , J.P. Volavka , J. 2006 . Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: Observational follow‐up study . British Medical Journal , 333 : 224
   PubMed Web of Science ®Google Scholar
• Tiihonen , J. , Lönnqvist , J. , Wahlbeck , K. , Klaukka , T. Niskanen , L. 2009 . 11‐year follow‐up of mortality in patients with schizophrenia: A population‐based cohort study (FIN11 study) . Lancet , 374 (9690) : 620 – 627 .
   PubMed Web of Science ®Google Scholar
• Timmer , T.J. and Fouwels , A.J. 2007 . [Choking caused by antipsychotics.] . Tijdschrift for Psychiatrie , 49 : 743 – 751 .
   PubMedGoogle Scholar
• von Hausswolff‐Juhlin , Y. , Bjartveit , M. , Lindstrom , E. and Jones , P. 2009 . “ Schizophrenia and physical health problems ” . In Acta Psychiatrica Scandinavica Suppl 15 – 21 .
   Google Scholar
• Waddington , J.L. , Youssef , H.A. and Kinsella , A. 1998 . Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10‐year prospective study . British Journal of Psychiatry , 173 : 325 – 329 .
   PubMed Web of Science ®Google Scholar
• Walker , A.M. , Lanza , L.L. , Arellano , F. and Rothman , K.J. 1997 . Mortality in current and former users of clozapine . Epidemiology , 8 : 671 – 677 .
   PubMed Web of Science ®Google Scholar
• Wang , H.D. , Dunnavant , F.D. , Jarman , T. and Deutch , A.Y. 2004 . Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat . Neuropsychopharmacology , 29 : 1230 – 1238 .
   PubMed Web of Science ®Google Scholar
• Weinberger , D.R. and McClure , R.K. 2002 . Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: What is happening in the schizophrenic brain? . Archives of General Psychiatry , 59 : 553 – 558 .
   PubMed Web of Science ®Google Scholar
• Weinmann , S. , Read , J. and Aderhold , V. 2008 . Influence of antipsychotics on mortality in schizophrenia: Systematic review . Schizophrenia Research , 113 : 1 – 11 .
   Web of Science ®Google Scholar
• Weiser , M. , Knobler , H. , Lubin , G. , Nahon , D. , Kravitz , E. Caspi , A. 2004 . Body mass index and future schizophrenia in Israeli male adolescents . Journal of Clinical Psychiatry , 65 : 1546 – 1549 .
   PubMed Web of Science ®Google Scholar